Introduction {#Sec1}
============

The kidney plays a central role in the regulation of electrolyte homeostasis and blood pressure and its dysregulation has been associated with several cardiovascular diseases (CVD)^[@CR1]--[@CR3]^.

Arterial vascular disease, characterized by increased systolic blood pressure and atherosclerosis, are the primary types of CVD present in patients with kidney failure^[@CR4]^. Atherosclerosis is an intimal disease produced by the presence of plaques that cause occlusive lesions^[@CR5]^. A surrogate marker of atherosclerosis is the intima-media thickness of the carotid wall (cIMT)^[@CR6]^. cIMT is easily detectable by ultrasound and is also regarded as an indicator of preclinical atherosclerosis in children^[@CR7]^.

In fact, renal size may be a marker for the loss of kidney mass and function^[@CR8],[@CR9]^, as several authors have described associations between renal volume, nephron mass and kidney disease^[@CR10]--[@CR12]^. Besides renal volume, renal length has also been associated with nephron mass and renal function (estimated by GFR)^[@CR13]--[@CR15]^. In children, the studies are scarce but indicate that renal size positively correlates with its functionality^[@CR16]^.

Several studies have examined the relationship between blood pressure and kidney measurements in different groups of patients^[@CR17]--[@CR20]^; however, there is a great discrepancy in the results derived from these studies and no investigations have been performed in healthy children. cIMT has been associated with renal function in adults^[@CR21]--[@CR24]^ and perirenal fat in children^[@CR25]^; however, studies about the association between cIMT and renal size are lacking.

Given that there is an accumulating body of evidence suggesting an association between kidney measurements and CVD, and that cardiovascular risk factors may be present in early life, we aimed to study the association between renal size (length and volume) and cardiovascular risk parameters (cIMT and SBP) in children in order to identify novel markers that can be easily assessed and used in the early prevention of CVD.

Results {#Sec2}
=======

Clinical, laboratory and ultrasonography assessments are shown in the studied subjects as a whole and in subgroups thereof according to BMI (lean, overweight and obese) (Table [1](#Tab1){ref-type="table"}). Renal parameters (length, volume and perirenal fat) were higher in overweight and obese, compared to lean children (all p \< 0.0001) and in obese, compared to overweight children (all p \< 0.0001).Table 1Clinical, laboratory and ultrasonography assessments in the studied subjects as a whole and in subgroups thereof according to BMI (lean, overweight and obese).All subjects (n = 515)Lean (BMI-SDS \<1) (n = 176)Overweight (1\< BMI-SDS \<2) (n = 208)Obese (BMI-SDS \>2) (n = 131)**Clinical assessments**Age (year)8.7 ± 0.18.1 ± 0.28.9 ± 0.1\*\*9.3 ± 0.2\*\*Gender (%F)45.046.045.742.7Birth weight (kg)3.1 ± 0.12.9 ± 0.13.1 ± 0.1\*3.3 ± 0.1\*\*Birth weight-SDS0.09 ± 0.07−0.41 ± 0.10.27 ± 0.1\*\*0.54 ± 0.2\*\*Weight (kg)39.7 ± 0.726.0 ± 0.641.8 ± 0.8\*\*54.9 ± 1.3\*\*^ππ^Weight-SDS0.95 ± 0.07−0.62 ± 0.051.16 ± 0.05\*\*2.74 ± 0.08\*\*^ππ^Height (cm)135.6 ± 0.6128.3 ± 1.1137.7 ± 0.9\*\*142.1 ± 1.1\*\*^ππ^Height-SDS0.53 ± 0.05−0.03 ± 0.090.68 ± 0.08\*\*1.05 ± 0.1\*\*^π^BMI (kg/m^2^)20.75 ± 0.2115.4 ± 0.121.5 ± 0.2^\*^\*26.7 ± 0.3\*\*^ππ^BMI-SDS0.85 ± 0.06−0.8 ± 0.031.1 ± 0.04\*\*2.7 ± 0.06\*\*^ππ^BSA (m^2^)1.2 ± 0.010.9 ± 0.011.3 ± 0.02\*\*1.5 ± 0.02\*\*^ππ^Fat mass (Kg)9.8 ± 0.44.7 ± 0.310.9 ± 0.6\*\*14.9 ± 1.1\*\*^π^Waist (cm)68.2 ± 0.754.4 ± 0.471.2 ± 0.7\*\*82.2 ± 1.2\*\*^ππ^SPB (mmHg)108.5 ± 0.5103.7 ± 0.6109.7 ± 0.7\*\*113.1 ± 0.9\*\*^ππ^DBP (mmHg)62.4 ± 0.460.1 ± 0.561.9 ± 0.5\*66.5 ± 0.8\*\*^ππ^**Laboratory assessments**Insulin (mIU/L)6.9 ± 0.33.2 ± 0.26.9 ± 0.4\*\*11.5 ± 0.7\*\*^ππ^HOMA-IR1.5 ± 0.10.7 ± 0.051.5 ± 0.08\*\*2.5 ± 0.2\*\*^ππ^Triacylglycerol (mg/dL)66.2 ± 1.648.9 ± 1.468.4 ± 2.6\*\*85.2 ± 3.7\*\*^ππ^HDL-cholesterol (mg/dL)42.5 ± 0.340.7 ± 0.643.3 ± 0.5\*43.7 ± 0.6\*Urea (mg/dL)30 ± 0.330.9 ± 0.529.7 ± 0.529.4 ± 0.6\*eGFR (mL/min per 1.73 m^2^)150.2 ± 1148.7 ± 1.7149.7 ± 1.6152.9 ± 2.1ALT (U/L)19.4 ± 0.416.1 ± 0.319.2 ± 0.5\*24.3 ± 1.1\*\*^ππ^GGT (U/L)13.8 ± 0.211.5 ± 0.213.8 ± 0.3\*\*16.9 ± 0.5\*\*^ππ^**Ultrasonography assessments**Renal length (cm)8.9 ± 0.058.2 ± 0.079.0 ± 0.06\*\*9.5 ± 0.09\*\*^ππ^Renal volume (cm^3^)81.2 ± 1.267.2 ± 1.583.1 ± 1.7\*\*97.2 ± 2.5\*\*^ππ^Perirenal fat (cm)0.20 ± 0.0020.18 ± 0.0040.20 ± 0.004\*0.23 ± 0.005\*\*^ππ^cMT (cm)0.040 ± 0.0000.038 ± 0.0000.040 ± 0.000\*0.043 ± 0.000\*\*^ππ^Data are shown as mean ± SEM. BMI, body mass index; SDS, standard deviation score; BSA, body surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; ALT: alanine-aminotransferase; GGT: gamma-glutamyl transferase; cIMT, carotid intima-media thickness. \*\*p \< 0.0001 vs Lean, \*p \< 0.05 vs Lean, ^ππ^p \< 0.0001 vs Overweight, ^π^p \< 0.05 vs Overweight.

In all the studied subjects, renal length and renal volume associated significantly and positively with several anthropometric and cardiovascular risk parameters including weight-SDS, height-SDS, BMI-SDS, BSA, waist, fat mass, SBP, DBP, insulin, HOMA-IR, TG, creatinine and cIMT and negatively with HDL-cholesterol (all p \< 0.001) (Table [2](#Tab2){ref-type="table"}).Table 2Correlation coefficients for renal length and renal volume with clinical, laboratory and ultrasonography assessments in the study subjects.Renal lengthRenal volumerPrP**Clinical assessments**Age (year)0.619\<0.00010.641\<0.0001Birth Weight-SDS0.235\<0.00010.216\<0.0001Birth Height-SDS0.262\<0.00010.229\<0.0001Weight-SDS0.520\<0.00010.503\<0.0001Height-SDS0.370\<0.00010.337\<0.0001BMI-SDS0.483\<0.00010.470\<0.0001BSA (m^2^)0.740\<0.00010.762\<0.0001Waist (cm)0.615\<0.00010.604\<0.0001Fat Mass (Kg)0.426\<0.00010.471\<0.0001SPB (mmHg)0.458\<0.00010.450\<0.0001DBP (mmHg)0.217\<0.00010.213\<0.0001**Laboratory assessments**Insulin (mIU/L)0.410\<0.00010.451\<0.0001HOMA-IR0.409\<0.00010.447\<0.0001Triacylglycerol (mg/dL)0.233\<0.00010.243\<0.0001HDL-cholesterol (mg/dL)−0.297\<0.0001−0.263\<0.0001Creatinine (μmol/L)0.314\<0.00010.309\<0.0001Urea (mg/dL)−0.0880.04−0.051NseGFR (mL/min)0.1230.0050.1230.005ALT (U/L)0.285\<0.00010.321\<0.0001GGT (U/L)0.361\<0.00010.390\<0.0001**Ultrasonography assessments**Renal length (cm)------0.758\<0.0001Renal volume (cm^3^)0.758\<0.0001------Perirenal fat (cm)0.422\<0.00010.397\<0.0001cIMT (cm)0.408\<0.00010.311\<0.0001p and r values are from Pearson correlation analyses. BMI, body mass index; SDS, standard deviation score; BSA, body surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; ALT: alanine-aminotransferase; GGT: gamma-glutamyl transferase; cIMT, carotid intima-media thickness.

The associations of renal length and renal volume with cIMT and SBP were significant in all BMI subgroups (all between p \< 0.05 and p \< 0.0001), although they were predominant (higher correlation coefficients) in obese children (Fig. [1](#Fig1){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}). A number of these associations were maintained after adjusting for age, gender and BSA (Table [4](#Tab4){ref-type="table"}). Renal length associated with cIMT in all studied subgroups and with SBP in obese children, while renal volume associate with cIMT and SBP in obese children (all p \< 0.05). We also evaluated the interaction effect of obesity in theses associations and the results showed a significant interaction of obesity in the association between renal length and SBP (p = 0.03).Figure 1Correlations between renal length and renal volume with cIMT and SBP according to BMI categories. White dots and dotted lines indicate lean children (BMI-SDS \< 0), grey dots and dashed line indicate overweight children (0 \< BMI-SDS \< 2) and black dots and continuous line indicate obese children (BMI-SDS ≥ 2).Table 3Correlation coefficients for cardiovascular risk factors (cIMT and SBP) with renal parameters in the study subjects as a whole and in subgroups thereof according to BMI (lean, overweight and obese).All children (n = 515)Lean (BMI-SDS \<1) (n = 176)Overweight (1\< BMI-SDS \<2) (n = 208)Obese (BMI-SDS \>2) (n = 131)cIMTrprprprpRenal length0.408\<0.00010.336\<0.00010.3530.0010.2910.001Renal volume0.311\<0.00010.1520.040.2140.0020.2680.002**SBPrprprprp**Renal length0.458\<0.00010.293\<0.00010.287\<0.00010.468\<0.0001Renal volume0.450\<0.00010.301\<0.00010.274\<0.00010.459\<0.0001p and r values are from Pearson correlation analyses. cIMT: carotid intima-media thickness, SBP: systolic blood pressure.Table 4Multivariate linear regression analysis for cardiovascular risk factors (cIMT and SBP) and renal parameters adjusted for age, gender and BSA in the study subjects as a whole and in subgroups thereof according to BMI (lean, overweight and obese).All children (n = 515)Lean (BMI-SDS \<1) (n = 176)Overweight (1\< BMI-SDS \<2) (n = 208)Obese (BMI-SDS \>2) (n = 131)cIMTBpBpBpBpRenal length0.376\<0.00010.347\<0.00010.410\<0.00010.3090.008Renal volume0.1540.01------------0.2690.03**SBP**Renal length0.1200.02------------0.2770.008Renal volume------------------0.2350.04cIMT: carotid intima-media thickness, SBP: systolic blood pressure, BSA: body surface area.

We were also interested to know if both renal length and perirenal fat were able to independently predict these cardiovascular risk parameters. To this aim, we performed additional multiple regression analyses of cIMT and SBP as dependent variables in the whole group of studied children. In these models, we computed both renal length and perirenal fat as independent variables, together with age, gender, BSA, and serum lipids. The regression model of cIMT showed that renal length (β = 0.310, p \< 0.0001) and perirenal fat (β = 0.233, p \< 0.0001) were independent predictors of cIMT and explained 21.1% of the variance in cIMT. The regression model of SBP showed that renal length (β = 0.116, p = 0.03) and BSA (β = 0.463, p \< 0.0001) were independent predictors of SBP and explained 30.7% of the variance in SBP (Table [5](#Tab5){ref-type="table"}).Table 5Multivariate linear regression analyses for cardiovascular risk factors (cIMT and SBP) and renal parameters after further adjusting for perirenal fat and serum lipids in the studied subjects as a whole (n = 515).BetaSig**cIMT**Renal length0.310\<0.0001Perirenal fat0.233\<0.0001R^2^0.211**SBP**Renal length0.1160.03BSA0.463\<0.0001R^2^0.307cIMT, carotid intima-media thickness; SBP, systolic blood pressure;Non predictive variables: age, gender, renal volume and lipids.

Discussion {#Sec3}
==========

Our study showed that renal size associated with cIMT and SBP, independently of other well-established risk factors such as age, gender, BSA and serum lipids in healthy prepubertal children.

The size of the kidney varies and is mainly affected by age, gender, height and BMI^[@CR26]^. Kidney size provides a rough indication of renal function and seems to be related to a number of risk factors for cardiovascular disease; however, the studies reporting relationships between renal size and blood pressure have shown controversial findings. For instance, renal volume adjusted for sex, age and BSA was inversely correlated with SBP in a study of Australian aboriginal children and adults (n = 668)^[@CR19]^. These results could be attributable to the rather low birth weight of the studied subjects, a common characteristic (up to 60%) among aboriginal people. It is known that low nephron numbers and higher blood pressure could be caused by fetal adaptation to intrauterine growth-restriction^[@CR27]^. However, Gurusinghe *et al*.^[@CR18]^ showed that total kidney volume was positively associated with SBP indices in children below 21 years (n = 84) diagnosed with primary hypertension, contrary to which they were expecting since hypertensive patients are found to have fewer glomeruli than their normotensive counterparts^[@CR28]^. They claimed that low birth weight may have a greater impact on BP with increasing age^[@CR29]^. Yet, other studies disclosed that there is no significant correlation between blood pressure and renal size in healthy adults (n = 185), after correcting for age, sex and BMI^[@CR30]^. Similarly, renal volume was related to renal function but not with blood pressure in a population-based cohort study of children (n = 6397)^[@CR31]^. In a study of hypertensive and control adult patients (n = 195)^[@CR32]^, the authors found a correlation between BMI, birth weight, renal volume and blood pressure only in the hypertensive group.

Our findings in healthy prepubertal children showed that renal length and volume associate with SBP mainly in obese children. In fact, it is known that overweight and obese subjects have greater carotid diameters and measures of adiposity and higher SBP^[@CR33]^. These associations were not explained by body surface, as they were independent of BSA in our study population.

Interestingly, similar associations were observed between renal length and volume and cIMT. As far as we are aware, this is the first description of an independent association between renal size and cIMT in healthy children. Indeed, previous works have focused on the association between several cardiovascular risk markers and impairment of renal function in adult patients. In hypertensive patients, cIMT correlated with increased concentration of cystatin C (n = 87)^[@CR34]^ and, in another study, cIMT correlated with low eGRF (n = 1351)^[@CR23]^. Others showed that atherosclerosis was a predictor of renal size and function in patients with atherosclerotic vascular disease (n = 1056)^[@CR22]^. A lack of independent relationship between renal function and atherosclerosis in subjects with normal renal function was also described^[@CR23],[@CR24]^. Similar results were observed in our cohort of healthy prepubertal children. eGRF correlated with cIMT; however, the associations were not maintained in multivariate analysis including BSA and other confounding variables.

Our multivariate analyses showed that renal length together with perirenal fat were independent predictors of cIMT. Importantly, we have previously demonstrated a strong association between perirenal fat and cIMT, considering perirenal fat as a cardiovascular risk enhancer^[@CR25]^. We suggested that the harmful impact of perirenal fat could be related to the local synthesis of adipocytokines that may impact on renal function. Renal size has also been previously proposed to play a role in estimating renal function in healthy children^[@CR16]^. Hence, the present results pointed that perirenal fat and renal size could both modulate vascular function and thus be associated with cardiovascular risk. In these sense, there is a study in Ossabaw pigs with metabolic syndrome that shows that greater renal size and higher glomerular filtration rate associated with microvascular proliferation and proximal tubular vacuolization, as well as significant intrarrenal and perirenal adiposity^[@CR35]^.

We have used renal length and volume to assess renal size. Both measures correlated with cIMT and SBP; however, in multivariate analysis, renal length, but no renal volume, was an independent predictor of cIMT and SBP. This discrepancy could be explained because of the better repeatability and accuracy of renal length measurements compared to renal volume. Several authors suggest that renal length may be a better marker than renal volume because is easily reproduced and less technically demanding than renal volume, which requires several measurements in different planes and the application of a formula^[@CR19],[@CR36]^.

We recognize a number of limitations in our study. In particular, the study has a cross sectional design, therefore it is not possible to explore a causative relationship between renal size and cardiovascular measures. However, this study seeks an interesting age group since atherosclerosis begins in childhood^[@CR7]^. Moreover, children are not subjected to potential confounding conditions such as adult-onset metabolic complications. Our findings are additionally limited to a pediatric population of 515 healthy patients, indicating that future investigations are needed to confirm the link between renal length and cardiovascular risk. We have observed significant independent associations between renal size (length and volume) and SBP but not with DBP; however, SBP is considered to be a better parameter associated with CV risk^[@CR37],[@CR38]^. Regarding the methodology, we have not measured intrarenal resistive index and even though both kidneys were measured, we only show data for the right one, as the measurements of the left kidney were less reproducible in our study. Blood pressure was only measured on the right arm; however, all subjects had normal femoral pulse suggesting that none had aortic coarctation. Our study may have not excluded subjects with spurious hypertension, but we could not determine central SBP because it is an invasive measurement. cIMT was only measured on the right artery; however, we have shown consistent results regarding the association of cIMT with CV risk in a number of manuscripts^[@CR39],[@CR40]^. No external validations for the ultrasound measurements were performed; however, cIMT and renal size have been shown to be easily and reproducibly measured by ultrasound in numerous studies^[@CR41],[@CR42]^.

In conclusion, our findings showed that renal size associated with cIMT and SBP, independently of other well-established risk factors. Renal length and perirenal fat were independent predictors of cIMT, while renal length and BSA were independent predictors of SBP. We propose that these renal parameters may play a role in the regulation of vascular function and may represent helpful parameters for the early prevention of cardiovascular risk in children.

Methods {#Sec4}
=======

Subjects and Ethics {#Sec5}
-------------------

The study population consisted of 515 asymptomatic Caucasian children (283 boys and 232 girls; mean age 8.7 ± 0.1 years); 176 lean (BMI-SDS \< 1); 208 overweight (1 ≤ BMI-SDS \< 2) and 131 obese (BMI-SDS ≥ 2). Subjects were enrolled in a study of obesity and cardiovascular risk factors in prepubertal childhood and consecutively recruited among those seen in a primary care setting in Girona, a region in Northeastern Spain.

The inclusion criteria were 1) age between 6 and 10 years and 2) prepubertal status (Tanner stage I). Children with major congenital anomalies; abnormal liver, kidney or thyroid functions; evidence of chronic illness or prolonged use of medication; acute illness or use of medication in the month preceding potential enrolment were excluded from the study.

The study protocol was approved by the Institutional Review Board of Dr Josep Trueta Hospital. All research was performed in accordance with relevant guidelines and regulations. Informed written consent was obtained from all the parents.

Clinical assessments {#Sec6}
--------------------

Clinical examination was performed in the morning, in the fasting state, and it was followed by venous blood sampling. Weight and height were measured with a calibrated scale and a Harpenden stadiometer, respectively. Body mass index (BMI) was calculated as weight (in kg) divided by the square of height (in meters). Age-adjusted and sex-adjusted standard deviation scores (SDS) for BMI were calculated using regional normative data^[@CR43]^. Body surface area (BSA) was calculated as the square root of height (in cm) \* weight (in kg)/3600. Waist circumference was measured in the supine position at the umbilical level. Body composition was assessed by bioelectric impedance (Hydra Bioimpedance Analyzer 4200, Xitron Technologies, San Diego, CA). Fat mass (FM) percentage was calculated using the body weight and lean mass parameters \[FM = (body weight − lean mass)/\*100\]. Systolic (SBP) and diastolic (DBP) blood pressure was measured on the right arm after a 10-min rest in the supine position by means of an electronic sphygmomanometer (Dinamap Pro 100, GE Healthcare, Chalfont St. Giles, United Kingdom). It was determined twice and an additional measurement was taken in case there was no agreement between the initial two measurements. Data are presented as the average of two concordant measurements. Information about birth parameters was abstracted from standardized medical records.

Laboratory assessments {#Sec7}
----------------------

All serum samples were obtained between 8:00 and 9:00 AM under fasting conditions. Fasting serum glucose, immunoreactive insulin, serum alanine-aminotransferase (ALT), gamma-glutamyl transferase (GGT), creatinine, urea and lipids (total cholesterol, triglycerides and HDL-cholesterol) were routinely assessed in the clinical laboratory of the Hospital Dr. Josep Trueta (Architect system, Abbott Diagnostics Europe, Milan, Italy). Insulin resistance was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR = \[fasting insulin in mUl^−1^\] \* \[fasting glucose in mM\]/22.5). Glomerular filtration rate (GFR) was estimated by the Haycock-Schwartz formula as follows: *K* × height (in cm)/creatinine (in umol/L), with a *K* value of 46 for all ages^[@CR44]^.

Ultrasound assessments {#Sec8}
----------------------

Right kidney size (length, depth and width), perirenal fat and cIMT were measured by high-resolution ultrasonography (MyLabTM25, Esaote, Firenze, Italy). Averages of three measurements for each parameter were used in the study. Renal size was measured in both kidneys with the subjects placed in left lateral supine position. Given that the right kidney was more easily assessed, and so these measurements were more reproducible, we only show data of the right one. During ultrasound measurements, participants with abnormal morphometry in any of the kidneys, suggesting renal scar, reflux nephropathy, and those with asymmetric kidneys, were further excluded from the study. Renal volume was calculated using the following formula \[length \* depth \* width \* 0.523\]^[@CR45]^. cIMT was measured on the right side at the level of the distal common carotid artery, one cm away from its bifurcation. Diastolic images were obtained using a linear 7.5--12 MHz transducer. Perirenal fat images were obtained using a convex 3--3.5 MHz transducer and fat thickness was measured as the distance from the inner side of the abdominal musculature to the surface of the right kidney. All measurements were performed by the same observer who was unaware of the clinical and laboratory characteristics of the subjects. Intra-subject coefficient of variation for ultrasound measurements was less that 6%. None of the children in our study showed ultrasonographic signs of atherosclerotic plaques.

Statistics {#Sec9}
----------

Statistical analyses were performed using SPSS version 22.0 (SPSS Inc., Chicago, IL). Results are expressed as mean ± standard error of the mean (SEM). Logarithmic transformation was used to obtain normally distributed values for continuous variables. Differences across obesity groups were examined by ANOVA (continuous data). The relation between variables was analyzed by Pearson bivariate correlations followed by multivariate linear regression analyses. The enter method was used for computing the independent variables. Significance level was set at p \< 0.05.
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